Skip to Content

G 408 (Propafenone Hydrochloride Extended-Release 225 mg)

Pill with imprint G 408 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by Glenmark Pharmaceuticals Inc., USA.

Propafenone is used in the treatment of atrial fibrillation; wolff-parkinson-white syndrome; ventricular tachycardia; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 408

Propafenone hydrochloride extended-release 225 mg G 408

Propafenone Hydrochloride Extended-Release

Imprint
G 408
Strength
225 mg
Color
White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc., USA
Manufacturer
Glenmark Pharmaceuticals Limited
National Drug Code (NDC)
68462-0408
Inactive Ingredients
ferrosoferric oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, shellac, sodium lauryl sulfate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "G 408"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.